Department of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, PR China.
Neuroscience. 2011 Sep 8;190:328-38. doi: 10.1016/j.neuroscience.2011.06.011. Epub 2011 Jun 13.
The 5-hydroxytryptamine (5-HT)-7 receptor began to be cloned and pharmacologically characterized close to 20 years ago. It couples positively via G-proteins to adenylyl cyclase and activation of this receptor increases neuronal excitability, and several studies have shown that degeneration of the nigrostriatal pathway leads to an impairment of 5-HT system. Here we reported that systemic and local administration of 5-HT₇ receptor agonist AS 19 produced excitation, inhibition and no change in the firing rate of pyramidal neurons in medial prefrontal cortex (mPFC) of normal and 6-hydroxydopamine-lesioned rats. In normal rats, the mean response of the pyramidal neurons to AS 19 by systemic and local administration in mPFC was excitatory. The inhibitory effect by systemic administration of AS 19 was reversed by GABA(A) receptor antagonist picrotoxinin. Systemic administration of picrotoxinin excited all the neurons examined in normal rats, and after treatment with picrotoxinin, the local administration of AS 19 further increased the firing rate of the neurons. In the lesioned rats, systemic administration of AS 19, at the same doses, also increased the mean firing rate of the pyramidal neurons. However, cumulative dose producing excitation in the lesioned rats was higher than that of normal rats. Systemic administration of AS 19 produced inhibitory effect in the lesioned rats, which was partially reversed by picrotoxinin. The local administration of AS 19, at the same dose, did not change the firing rate of the neurons in the lesioned rats. Systemic administration of picrotoxinin and the local administration of AS 19 did not affect the firing rate of the neurons in the lesioned rats. These results indicate that activity of mPFC pyramidal neurons is regulated through activation of 5-HT₇ receptor by direct or indirect action, and degeneration of the nigrostriatal pathway leads to decreased response of these neurons to AS 19, suggesting dysfunction and/or down-regulation of 5-HT₇ receptor on the pyramidal neurons and GABA interneurons in the lesioned rats.
5-羟色胺(5-HT)-7 受体在大约 20 年前开始被克隆并进行药理学特征分析。它通过 G 蛋白与腺苷酸环化酶呈正耦联,激活该受体可增加神经元兴奋性,多项研究表明,黑质纹状体通路的退化导致 5-HT 系统功能障碍。在这里,我们报道 5-HT₇ 受体激动剂 AS 19 的全身和局部给药可引起正常和 6-羟多巴胺损伤大鼠内侧前额叶皮质(mPFC)锥体神经元的放电频率兴奋、抑制和不变。在正常大鼠中,全身和局部给药 AS 19 对 mPFC 中锥体神经元的平均反应是兴奋的。全身给予 AS 19 的抑制作用可被 GABA(A) 受体拮抗剂 picrotoxin 逆转。全身给予 picrotoxin 兴奋了正常大鼠中检查的所有神经元,并且在用 picrotoxin 处理后,局部给予 AS 19 进一步增加了神经元的放电频率。在损伤大鼠中,相同剂量的全身给予 AS 19 也增加了锥体神经元的平均放电频率。然而,损伤大鼠中产生兴奋的累积剂量高于正常大鼠。全身给予 AS 19 在损伤大鼠中产生抑制作用,该作用可被 picrotoxin 部分逆转。相同剂量的 AS 19 局部给药未改变损伤大鼠神经元的放电频率。全身给予 picrotoxin 和局部给予 AS 19 均未影响损伤大鼠神经元的放电频率。这些结果表明,通过直接或间接作用激活 5-HT₇ 受体可调节 mPFC 锥体神经元的活动,黑质纹状体通路的退化导致这些神经元对 AS 19 的反应降低,提示损伤大鼠中 5-HT₇ 受体在锥体神经元和 GABA 中间神经元上的功能障碍和/或下调。